THESEUS PHARMACEUTICALS INC (THRX) Stock Analyst Earnings Estimates
NASDAQ:THRX - Nasdaq - US88369M1018 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 3,419.06% | N/A 154.20% | N/A 12.67% | N/A 10.86% | |||||
| EBITDA YoY % growth | -4.94M | -6.84M -38.46% | -27.34M -299.71% | -54.04M -97.66% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.94M | -6.84M -38.46% | -27.34M -299.71% | -54.09M -97.84% | N/A -20.69% | N/A 31.56% | N/A -15.30% | N/A -70.07% | N/A 121.99% | N/A 790.61% | N/A 20.60% | N/A 16.37% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.30 25.68% | N/A -0.43% | N/A 26.56% | N/A 24.47% | N/A -130.52% | N/A 113.75% | N/A 584.44% | N/A 20.78% | N/A 16.13% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 15.49% | -0.45 -32.00% | -0.45 -32.00% | -0.42 -36.55% | -0.43 -46.55% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.26M 14.34% | -21.318M -24.96% | -21.318M -21.19% | -22.134M -34.96% | -22.134M -66.92% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.31 18.42% | -0.37 | 0.06 | 15.58% |
| Q2 2023 Q2Q % growth | -0.34 -13.33% | -0.37 | 0.03 | 7.48% |
| Q1 2023 Q2Q % growth | -0.34 -25.93% | -0.43 | 0.09 | 20.47% |
| Q4 2022 Q2Q % growth | -0.35 -45.83% | -0.45 | 0.10 | 22.60% |
| Q3 2022 Q2Q % growth | -0.38 92.64% | -0.35 | -0.03 | -9.57% |
| Q2 2022 Q2Q % growth | -0.30 | -0.30 | 0.00 | 0.64% |
| Q1 2022 Q2Q % growth | -0.27 | -0.27 | 0.00 | 0.11% |
| Q4 2021 Q2Q % growth | -0.24 | -0.23 | -0.01 | -4.58% |
| Q3 2021 Q2Q % growth | -5.16 | -0.25 | -4.91 | -1,986.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 19.44% | 0% | 10.91% |
| Revenue | N/A | N/A | N/A | N/A |